Revenio Group Oyj (R0V)
Munich
Closed
Oct 9, 2026
Day's Range
11.0252 wk Range
10.42Overview - R0V - Revenio Group Oyj
Key Statistics
Valuation
Enterprise Value
711.40M
P/E (Trailing)
‪26.58‬
PEG Ratio
‪-0.30‬
Price / Sales (TTM)
‪3.04‬
Price / Book
‪2.52‬
EV / EBITDA
‪35.39‬
Profitability
Gross Margin
‪64.63%‬
Profit Margin
‪10.54%‬
Operating Margin
‪6.04%‬
Return on Assets
‪3.56%‬
Return on Equity
‪10.32%‬
Ownership
Shares Outstanding
26.60M
Float
27.96M
Held by Insiders
‪9.67%‬
Held by Institutions
‪51.36%‬
Price stats
Beta
‪0.87‬
50-Day Avg
‪13.26‬
200-Day Avg
‪16.21‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Annual
Market Cap - R0V - Revenio Group Oyj
Peers - R0V - Revenio Group Oyj
Peer Comparison
Compared with companies in Medical Devices listed on Munich.
- R0VMunichRevenio Group Oyj382.93MMarket Cap-109.17%52-week change26.59P/E (Trailing)‪10.54%‬Profit Margin
- TUO0MunichTerumo Corporation Unsponsored ADR19.02BMarket Cap-12.40%52-week change24.34P/E (Trailing)‪13.89%‬Profit Margin
- GTN0MunichGetinge AB Unsponsored ADR5.98BMarket Cap+13.89%52-week change24.83P/E (Trailing)‪7.81%‬Profit Margin
- EJXMunichElekta AB Unsponsored American Depositary Receipt1.78BMarket Cap+7.26%52-week change75.71P/E (Trailing)‪-2.18%‬Profit Margin
- 818MunichZylox-Tonbridge Medical Technology Co., Ltd.766.10MMarket Cap-13.79%52-week change17.85P/E (Trailing)‪25.24%‬Profit Margin
- 2K3MunichSI-BONE, Inc.467.02MMarket Cap+26.22%52-week change-37.27P/E (Trailing)‪79.57%‬Profit Margin
- VI4MunichVarex Imaging Corp.437.74MMarket Cap+35.40%52-week change-9.47P/E (Trailing)‪34.39%‬Profit Margin
Profile Summary - R0V - Revenio Group Oyj
About
Revenio Group Oyj is a Finnish health technology company and a global leader in ophthalmological devices and software solutions. It develops and commercializes effective, easy-to-use screening devices for detecting significant public health diseases, particularly in eye care. Its flagship offerings under the iCare…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
